Tolvaptan Add-on Therapy to Overcome Loop Diuretic Resistance in Acute Heart Failure With Renal Dysfunction (DR-AHF): Design and Rationale. [PDF]
Minh NG, Hoang HN, Maeda D, Matsue Y.
europepmc +1 more source
Prognostic impact of early versus delayed loop diuretic administration in sepsis: a propensity score-matched analysis using the MIMIC-IV database. [PDF]
Wang Y +5 more
europepmc +1 more source
Prognostic impact of outpatient loop diuretic reduction patterns in patients with chronic heart failure. [PDF]
Koike T +13 more
europepmc +1 more source
Torsemide Is a More Appropriate Oral Loop Diuretic for Patients with Heart Failure: CON. [PDF]
Lo KB, Rangaswami J.
europepmc +1 more source
Loop Diuretics in Heart Failure: The Objective Markers to Guide the Therapy are Needed [PDF]
Jan Biegus +2 more
openalex +1 more source
Azosemide is more potent than bumetanide and various other loop diuretics to inhibit the sodium-potassium-chloride-cotransporter human variants hNKCC1A and hNKCC1B [PDF]
Philip Hampel +3 more
openalex +1 more source
Loop Diuretic Prescription and 30-Day Outcomes in Older Patients With Heart Failure. [PDF]
Faselis C +15 more
europepmc +1 more source
Loop diuretic down-titration at discharge in patients hospitalized for acute heart failure. [PDF]
Croset F +12 more
europepmc +1 more source
Torsemide is a More Appropriate Oral Loop Diuretic for Patients with Heart Failure: Commentary. [PDF]
Coca SG.
europepmc +1 more source

